Kane Biotech Inc (KNBIF) Stock Price & News

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	8.50K	-21.14K	43.22K	8.14K
Cost of goods sold	13.63K	-28.71K	47.12K	6.70K
Cost of revenue	13.63K	-28.71K	47.12K	6.70K
Research and development expenses	159.64K	114.94K	208.80K	114.09K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	378.67K	522.13K	460.61K	671.84K
Operating expense	538.31K	637.07K	669.40K	785.93K
Total operating expenses	551.93K	608.36K	716.52K	792.63K
Operating income	-543.43K	-629.50K	-673.30K	-784.48K
Other non operating income	-	-	-	-
EBT including unusual items	-607.34K	-654.86K	-710.60K	-829.78K
EBT excluding unusual items	-607.34K	-633.88K	-731.00K	-829.78K
Income tax expense	-	-108.00K	4.22K	3.86K
Effective tax rate	-	16.49%	-0.59%	-0.46%
Other operating expenses	-	-	-	-
Net income	-607.34K	-546.86K	-714.83K	-833.64K
Net profit margin	-7,146.08%	2,586.83%	-1,654.00%	-10,237.46%
Earnings per share	-	-	-	-
Interest and investment income	7.95K	1.81K	3.08K	3.38K
Interest expense	-71.86K	-10.14K	-57.88K	-47.00K
Net interest expenses	-63.91K	-8.33K	-54.80K	-43.61K
Depreciation and amortization charges	-	-	-	-
EBITDA	-445.94K	-614.14K	-654.30K	-771.44K
Gain or loss from assets sale	-	-27.01K	1.76K	-

Finance